Maternal liver undergoes structural and metabolic changes during pregnancy to meet the demands of the developing fetus. In rodents, this involves increased liver weight, but the mechanism remains unclear. To address this, we analyzed the histology, gene expression, and DNA methylation of livers of nonpregnant and pregnant C57/BL6 mice. Gestational liver growth in pregnant mice was accompanied by increased hepatocyte area and lower cell density (days 14 and 18). Expression of cell proliferation markers was increased on days 14 and 18. A total of 115 genes were differentially expressed on day 14 and 123 genes on day 18 (79 on both days). Pathway analysis indicated that pregnancy involves progressive increase in cell proliferation and decreased apoptosis. This was confirmed using archived data from the FVB wild-type mouse liver transcriptome. Four differentially DNA methylated and two differentially DNA hydroxymethylated regions identified on days 14 and 18 by methylome-wide analysis, but were not associated with altered gene expression. Long interspersed nuclear element-1 hypomethylation on days 14 and 18 was accompanied by increased ten-eleven translocase-2 and decreased DNA methyltransferase 3a and 3b expression. These findings suggest that gestational liver growth involves increased mitosis and hypertrophy, and decreased apoptosis contingent on pregnancy stage. Such changes may involve repetitive sequence, but not gene specific, DNA methylation.
Introduction
Pregnancy involves adaptions to maternal liver metabolism to meet the nutritional and metabolic demands of the mother and the developing fetus [1] [2] [3] . In rodents and other small mammals, such metabolic adaptions [4] [5] [6] are accompanied by a marked increase in liver size to increase the functional capacity of the organ [7] [8] [9] . Gestational changes in liver weight are related to the demands of the conceptus such that in rodents litter size explains over 50% of the variation in the liver weight of the dam [10] . Thus, characterization of the mechanisms that underlie gestational liver growth is important for understanding the reproductive physiology of rodents and other species that exhibit increased liver weight during pregnancy. Furthermore, although the liver of pregnant women does not increase in size during pregnancy [11] , rodents are often used as models of human pregnancy. Understanding the regulation of liver growth in rodents may provide important insights into the findings of experiments using such models.
The mechanisms responsible for pregnancy-induced liver growth are poorly understood, but may include changes in hepatocyte size (hypertrophy), proliferation (hyperplasia), or apoptosis, or a combination of these processes. There is conflicting evidence about whether hepatocyte hypertrophy or hyperplasia, or both, are involved. This may reflect, at least in part, differences in experimental design. Hypertrophy without hyperplasia has been reported in some studies [12, 13] , and pregnancy has been shown to increase the regenerative capacity of the liver, primarily as the result of hypertrophy rather than hyperplasia [7, 14] . Moreover, hypertrophic liver cells can undergo increased proliferation during the postpartum period, which suggests that mitosis may be suppressed during pregnancy [14] . These findings are consistent with increased expression of the cell cycle activation marker Ki67 in pregnant liver without an increase in mitotic figures [10] . In contrast, others have shown that liver DNA content at term is almost twice that of nonpregnant rats and correlated positively with liver weight [15] . This suggests that pregnancy-induced cell cycle activation can progress through mitosis. Furthermore, comparison of the rat liver transcriptome at term pregnancy with nonpregnant animals showed changes in several genes that were consistent with active mitosis [15] . However, neither the overall effect on the transcriptome nor the pathways affected were reported. Furthermore, limiting analysis to term pregnant and nonpregnant liver prevented characterization of gene regulation with increasing gestational age.
Epigenetic processes confer regulation of transcription across different timescales [16, 17] . Importantly, such processes exhibit plasticity and can be modified by endocrine factors [18] although the underlying mechanisms are not understood. DNA methylation has been suggested to represent the equilibrium of methylation reactions [19] catalyzed by DNA methyltransferases (Dnmts) [17] and demethylation catalyzed by ten-eleven translocases (Tets) [20] . Altered epigenetic regulation of specific genes represents one possible mechanism by which the maternal liver adapts to pregnancy. However, the effect of pregnancy on epigenetic processes in the liver has not been described.
This study tested the hypothesis that liver growth in pregnancy in mice involves changes in the expression of the transcriptome in pathways associated with hypertrophy, cell proliferation, and apoptosis. We measured hepatocyte size and the expression of the liver transcriptome at different gestational ages in mice. Furthermore, in order to investigate the mechanisms underlying any pregnancy-associated changes in the gene expression, we measured the DNA methylation and hydroxymethylation status of the maternal liver genome.
Materials and methods

Ethics
The study was carried out in accordance with the United Kingdom Home Office Animals (Scientific Procedures) Act (1986) under Home Office Licence number 30/2884, and received institutional approval from the University of Southampton Biomedical Research Facility Research Ethics Committee (no ethical approval number).
Animal procedures
Virgin female C57/BL6 mice were fed Rat and Mouse No.1 Maintenance Diet (SDS, Essex, UK; see Supplemental Table S1 ) ad libitum from when they were weaned and maintained on a standard 12-h light/dark cycle throughout. Female mice at 90 days of age were mated. Once pregnancy had been established by the presence of a vaginal plug, females were removed and caged separately. Agematched virgin females were used as a nonpregnant, comparison group. Pregnant females were killed on pregnancy days 7, 14, and 18 (typical duration of pregnancy in this strain is 21 days). Nonpregnant females were killed at age 90 days. All animals were fasted for 6 h prior to killing by CO 2 asphyxiation with cervical dislocation. Livers were collected, weighed, frozen immediately in liquid nitrogen, and stored at -80
• C.
Histological procedures
Snap-frozen livers were fixed in optimal cutting temperature compound (Tissue-Tek, CA, USA), cut into 7 μm sections, and mounted onto glass slides. Analysis of morphology, cell size, and number was carried by staining with hematoxylin and eosin. Frozen sections were air-dried, immersed in 0.1% (w/v) Mayer's hematoxylin for 10 min, and washed in running water for 5 min. Sections were then immersed in 1% (w/v) eosin for 2 min and then washed under running water for 5 min. The sections were then dehydrated through increasing concentrations of ethanol, cleared in Clearene (Sigma-Aldrich, Dorset, UK), and mounted in Pertex (Histolab Gothenburg, Sweden). Sections were examined using an Eclipse E600 microscope (Nikon UK Ltd, Surrey, UK) with ×40 objective lens. A graticule image taken at the same magnification was used to scale the images. Ten fields were analyzed per section, and cell area was measured using image J software (Research Services Branch, MD, USA). Five nonoverlapping fields were analyzed per section to determine cell number using the ITCN Image J Pluggin (Bio-image Informatics, CA, USA) and drawing an area of 90 × 90 μm 2 . Two sections were analyzed per liver and three livers were analyzed at each gestational age.
RNA isolation and microarray analysis
Whole livers from nonpregnant and pregnant (days 14 and 18) mice (n = 8/group) were ground to a fine powder under liquid nitrogen using a pestle and mortar. RNA was extracted using Trizol (Sigma-Aldrich, Dorset, UK) as described [21] . RNA quantity and contamination with solvent and protein were assessed using a NanoDrop1000 (Labtech, Ringmer, East Sussex, UK). Transcriptome analysis was carried out using the Illumina MouseRef-8 v2.0 Expression BeadChip. Hybridization and data normalization were carried out by the Genome Centre (Barts and The London, School of Medicine and Dentistry, London, UK). Pathway analysis was carried out using Ingenuity IPA software (Qiagen, CA). These data were filtered in order to eliminate false positives. Transcripts with detection P > 0.05 and/or with nonsignificant differences between groups, and/or less than 2-fold change were excluded from further analysis. In order to extend the number of time points in pregnancy for analysis and to test the generalizability of our findings, we carried out secondary analysis of data derived from analysis of the liver transcriptome of FVB wild-type mice by the Affimetrix Mouse Gene 1.0 ST array held at the National Center for Biotechnology Information Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/) repository (accession number GSE41438). These data were derived from analysis of the effect of pregnancy on the liver transcriptome at gestational ages 7.5, 10, 15, and 19 days compared to nonpregnant animals. Findings from this experiment published previously were restricted to genes associated with drug metabolism [22] . These genes were not reported in the current analysis.
Quantitative RT-PCR
Quantitative RT-PCR was carried out essentially as described [23] using primers listed in Supplemental Table S2 . RNA was treated with DNase before conversion to complementary DNA. Complementary DNA (20 μl) conversion was used for PCR amplification using SYBR Green [23] . Data were analyzed using the standard curve method [24] . The housekeeping genes, Gapdh and Rpl13a, were selected using the GeNorm kit (PrimerDesign, Southampton, UK) [25] .
Methylation and hydroxymethylation-dependent immunoprecipitation with next generation sequencing
Genomic DNA was isolated [23] , quantified using a NanoDrop1000, and the integrity and RNA contamination were assessed by bioanalyzer. Purified DNA was sonicated to 100-500 bp fragments, followed by DNA end repair and ligation of sequencing adaptors. The DNA was denatured and immunoprecipitation using a 5mC or 5hmC antibody followed by PCR amplification and library QC, prior to sequencing (six samples per lane 50PE) on a Hiseq2000. The sonication, immunoprecipitation, and sequencing were carried out by Beijing Genomics Institute (Beijing, China). The data were filtered by removing the adaptor sequences and low-quality reads. The MeDip-seq data were mapped to the reference genome using the Short Oligonucleotide Analysis Package2 (SOAP2) software pipeline with only unique alignments containing no more than two mismatches taken forward for further analysis. Whole-genome peak scanning was carried out using MACS1.4.0. For each differentially methylated region (DMR), the number of reads of each sample was calculated with probability of 0.05 or lower and a difference of read numbers more than twofold.
Bisulfite pyrosequencing
Validation of the MeDipSeq analysis was carried out by sodium bisulfite pyrosequencing essentially as described [23] . The choice of DMRs for validation was restricted by the ability to design sequencing assays (see Supplemental Figure S1 ). Hence, only the zinc finger CCCH-type containing 12D (Zc3h12d) DMR was validated by pyrosequencing. Briefly, genomic DNA was prepared and bisulfite conversion was carried out using the EZ DNA methylation kit (ZymoResearch, Irvine, CA, USA). Primers were designed to cover a 1.5-kb region encompassing 500 bp DMRs using PSQ Assay Design Software (Biotage, Uppsala, Sweden) (see Supplemental Table  S3 ; see Supplemental Figure S1 ). Modified DNA was amplified using KAPA2G Robust Hot Start Taq DNA polymerase (Labtech) and PCR primers listed in see Supplemental Table S2 . PCR products were immobilized on streptavidin-sepharose beads (GE Healthcare UK Ltd, Amersham, Buckinghamshire, UK), washed, denatured, and released into annealing buffer containing the sequencing primers (see Supplemental Table S2 ). Methylation analysis was carried out using the SQA kit on a PSQ 96MA pyrosequencer (Biotage), and percentage methylation was calculated using Pyro Q CpG software (Biotage) [23] .
Statistical analysis
Comparisons between different time points in pregnancy were by one-way ANOVA with Tukey's post hoc correction for multiple comparisons using SPSS software (IBM SPSS Statistics for Apple Macintosh, Version 20.0; IBM Corporation, Armonk, NY, USA). Statistical significant was assumed at a probability of <0.05. Statistical analysis of microarray data was through the IPA analytical software package as described in the relevant sections.
Results
Liver growth was associated with hyperplasia and hypertrophy
As expected, pregnancy caused a statistically significant increase in liver weight at 7, 14, and 18 days gestation (ANOVA P < 0.0001; Figure 1A ). Hepatocyte area did not differ significantly from nonpregnant animals on day 7, but was greater on 14 (56%) and 18 (33%) days gestation (ANOVA P = 0.0016; Figure 2B ). Hepatocyte density did not differ significantly from nonpregnant animals on day 7, but was significantly lower on 14 (28%) and 18 (27%) days gestation (ANOVA P = 0.043; Figure 1C ). Pregnancy was associated with increased Ki67 and cyclin B1 expression which indicated activation of the mitotic cycle. Ki67 messenger RNA (mRNA) expression was greater (ANOVA P = 0.0006) at 7 (122%), 14 (131%), and 18 (78%) days gestation compared to nonpregnant animals ( Figure  1C ). Cyclin B1 mRNA expression was also greater than in nonpregnant animals (ANOVA P = 0.018) at 7 (53%) and 14 (83%) days gestation, but was not significantly different from nonpregnant liver on day 18 ( Figure 1D ).
Pregnancy induces gestational age-related changes in the liver transcriptome
To determine the changes in gene expression associated with these different stages of pregnancy, RNA from D14 and D18 was analyzed using the Illumina MouseRef-8 v2.0 Expression BeadChip. The expression of 115 transcripts (74 upregulated) differed by at least twofold (P < 0.05) between pregnancy day 14 and nonpregnant animals (see Supplemental Table S4 ). The expression of 123 transcripts differed (77 upregulated) by at least twofold on day 18 compared to nonpregnant animals (see Supplemental Table S4 ). Of these, 79 transcripts were altered at both time points, and 76 in the same direction (see Supplemental Table S4 ). Five genes were among the 10 most upregulated genes on both days 14 and 18 gestation compared to nonpregnant animals: Kallikrein 1 (Kik1b4), Crystallin Beta B3 (Crybb3), Serpin Family A Member 6 (Serpina6), Neural Precursor Cell Expressed, Developmentally Down-Regulated 9 (Nedd9), and Snail Family Transcriptional Repressor 3 (snai3) (see Supplemental  Table S4 ). Five genes were among the 10 most downregulated genes at both 14 and 18 days gestation compared to nonpregnant animals: Cytochrome P450, family 2, subfamily b, polypeptide 13 (Cyp2b13), ATP Binding Cassette Subfamily C Member 3 (Abcc3), Cytochrome P450, family 2, subfamily c, polypeptide 50 Cyp2c50 (Cyp2c50), Arginine Vasopressin Receptor 1A (Avpr1a), and Hepcidin Antimicrobial Peptide (Hamp) (see Supplemental Table S4 ). The (A) n = 20, nonpregnant, n = 15 at day 7, n = 10 at day 14, and n = 9 at day 18. (B) n = 3 livers from which two sections were taken from each, and 10 cells were counted from each section. (C) As (B), but five fixed fields were counted per section. (D) n = 5 for nonpregnant, n = 10 at day 7, n = 8 at day14, and n = 8 at day 18. (E) n = 5 for nonpregnant, n = 10 at day 7, n = 9 at 9 day14, and n = 9 at day 18. Different letters indicate mean that differed significantly (P < 0.01).
Illumina microarrays were validated by qRT-PCR for nine most altered genes (see Supplemental Figure S2 ). There was good agreement between the differences in expression measured by microarray and RT-PCR.
Compared to nonpregnant liver, the IPA categories enriched amongst the differentially expressed genes on day 14 were disease and disorders, molecular and cellular function, and physiological systems (Figure 2A-C) . The categories containing the most altered genes on day 18 were disease and disorders, molecular and cellular function, and physiological systems ( Figure 2D-F) . The subcategories altered relative to nonpregnant animals on day 18 were similar to those changed on day 14 with the exception of molecular transport which had greater representation on day 18 than on day 14 (see Supplemental Figure S3 ).
Confirmation of the predicted changes in the liver transcriptome in a second mouse strain
We sought to test the findings in C57BL/6 mice that were measured using the Illumina platform, by secondary analyses of published data of the liver transcriptome on pregnancy days 7.5, 10, 15, and 19 in FVB wild-type mice measured using the Affymetrix microarray platform [22] . Of the 115 genes, 43 genes that were altered on pregnancy day 14 compared to nonpregnant C57BL/6 mice were also altered in FVB mice on pregnancy day 15 (total differentially expressed genes 264). Of the 123 genes, 28 genes that were altered compared to nonpregnant animals on pregnancy day 18 in C57BL/6 mice were also altered in FVB mice on pregnancy day 19 (total differentially expressed genes 139) (see Supplemental Tables S5  and S6 ). The effect of pregnancy on the expression of genes in the cell proliferation and organismal death pathways We used data from both C57BL/6 and FVB mice to investigate the contribution of cell hyperplasia and apoptosis to maternal liver growth during pregnancy by focusing on the cell proliferation and organismal death pathways. Details of differentially expressed genes in the cell proliferation pathway are summarized in Supplemental  Table S5 . On pregnancy day 7.5, 16 genes in the cellular proliferation pathway were differentially expressed (11 (69%) predicted to upregulate the pathway) compared to nonpregnant FBV mice (activation z-score 3.166). On day 10, 31 genes in the cellular proliferation pathway were differentially expressed (20 (65%) predicted to upregulate the pathway) compared to nonpregnant FBV mice (activation z-score 3.031). On day 14, 22 genes associated with cell proliferation pathway were differentially expressed (11 (50%) predicted to upregulate the pathway) in pregnant compared to nonpregnant C57BL/6 mice (activation z-score 0.964). On pregnancy day 15, 34 genes in the cellular proliferation pathway were differentially expressed (17 (50%) predicted to upregulate the pathway) compared to nonpregnant FBV mice (activation Z-score 0.054). On day 18, 24 genes in the cellular proliferation pathway were differentially expressed (13 (54%) predicted to upregulate the pathway) compared to nonpregnant C57BL/6 mice (activation Z-score 1.595). On day 19, 27 genes were differentially expressed (16 (59%) (predicted to upregulate the pathway) compared to nonpregnant FBV mice (activation Z-score 2.112). On day 7.5, 17 genes associated with organismal death pathway were differentially expressed (12 (71%) predicted to downregulate the pathway) compared to nonpregnant FBV mice (activation z-score -2.112) (see Supplemental Table S6 ). On day 10, 33 genes associated with organismal death pathway were differentially expressed (22 (68%) predicted to downregulate the pathway) compared to nonpregnant FBV mice (activation z-score -2.112) (see Supplemental Table S3 ). On day 14, three genes associated with the organismal death were differentially expressed compared to nonpregnant C57BL/6 mice which was too few to predict the net effect on the pathway. On day 15, 58 genes involved in organismal death were differentially expressed (28 (48%) predicated to downregulate the pathway) compared to nonpregnant FBV mice (activation z-score -0.102). On day 18, 31 genes involved in organismal death were differentially expressed (24 (77%) predicated to downregulate the pathway) compared to nonpregnant C57BL/6 mice (activation zscore -1.027). On day 19, 24 genes involved in organismal death were differentially expressed (13 (54%) predicted to downregulate the pathway) compared to nonpregnant FBV mice animals, but these changes were not predicted to alter the overall activity of the pathway.
We tested the apparent suppression of apoptosis further by measuring the mRNA expression of key genes in the apoptotic pathway namely tumor protein-53 (Trp53), Fas receptor (Fas), and caspase 6 (Casp6) [26] in the liver of nonpregnant and pregnant C57BL/6 mice. Trp53 mRNA expression was significantly lower at pregnancy days 7 (33%), 14 (47%), and 18 (44%) compared to nonpregnant animals ( Figure 3A) . Fas mRNA expression was significantly lower at pregnancy days 7 (50%), 14 (55%), and 18 (48%) compared to nonpregnant animals ( Figure 3B ). Casp6 was significantly downreg- ulated only on pregnancy days 14 (51%) and 18 (54%), but did not differ significantly from nonpregnant animals on day 7 ( Figure 3C ).
Pregnancy-induced changes in the DNA methylome
Methylation-dependent immunoprecipitation and methyl immunoprecipitation sequencing were used to identify sequences that may be differentially methylated upon pregnancy. Four regions showed significantly lower (twofold) methylation in day 14 pregnant mice compared to nonpregnant animals ( Table 1) . Three regions were located within introns of ATPase phospholipid transporting 8A2 (Atp8a2), cell adhesion molecule-2 (Cadm2), and adenylate cyclaseassociated protein-2 (Cap2), and one in the coding sequence of zinc finger CCCH domain-containing protein 12D (Zc3h12d) ( Table 1) . Two regions showed significantly lower (twofold) hydroxymethylation in day 14 pregnant mice compared to nonpregnant animals (Table 1). These were located in the 5 untranslated region of membrane spanning 4-domains A1 (Ms4a1) and in the intron of latrophilin-3 (Lphn3). Validation of the change in the Zch12d DMR by pyrosequencing showed that 3/6 CpG loci covered by this region had lower methylation in day 14 pregnant compared to nonpregnant liver (see Supplemental Figure S4 ). There were no DMRs associated with genes involved in cell proliferation or apoptosis that were differentially expressed in pregnant versus nonpregnant liver.
The level of methylation of 3/4 CpG loci in the LINE-1 amplicon tested was significantly lower at 14 and 18 days gestation compared to liver from nonpregnant or day 7 pregnant mice ( Figure 4A ). Furthermore, average methylation across the LINE-1 region measured was significantly lower (ANOVA P < 0.0001) at 14 days (9%) and 18 days (8%) of gestation compared to nonpregnant or day 7 pregnant mice ( Figure 4B ). The LINE-1 transcript was not detected in liver from nonpregnant or pregnant mice.
Pregnancy-associated changes in expression of DNA methyltransferases and ten-eleven translocases
Dnmt3a mRNA expression was lower compared with nonpregnant animals on pregnancy days 14 (60%) and day 18 (39%), but did not differ significantly on pregnancy day 7 (ANOVA P = 0.0046; Figure 5A ). Dnmt3b mRNA expression was lower compared with nonpregnant animals on pregnancy days 14 (51%) and day 18 (17%), but did not differ significantly on pregnancy day 7 (ANOVA P = 0.011; Figure 5B ). There was no significant effect of pregnancy on Dnmt1 expression ( Figure 5C ). Tet2 mRNA expression was increased compared to nonpregnant animals on pregnancy days 7 (122%), 14 (188%), and 18 (136%) (ANOVA P = 0.019; Figure 5E ). There were no significant differences between pregnant and nonpregnant animals in the mRNA expression of Tet1 or 3 ( Figure 5D and F).
Discussion
The findings of this study show that the pregnancy-associated increase in liver size was associated with hypertrophy, and with changes in the expression of the transcriptome that were consistent with increased proliferation and decreased apoptosis during specific periods in gestation. However, the findings did not support the suggestion that pregnancy-associated changes in the hepatic transcriptome involve altered gene-specific DNA methylation. Although it is well established that the maternal liver adapts to pregnancy both in terms of size and function, there have been relatively few studies into underlying mechanisms and consequently there are conflicting observations about the relative contribution of key cellular processes, specifically hypertrophy and hyperplasia, to maternal liver growth [10, [12] [13] [14] [15] . The present findings show that the rapid period of liver growth in mid and late gestation was accompanied by hyperplasia and/or hypertrophy in pregnant rodents [12] [13] [14] . Messenger RNA expression of Ki67 and cyclin B1 was increased on pregnancy days 7 and 14 which suggests that maternal liver growth in early pregnancy involves primarily hypertrophy, while in mid gestation was associated with both hypertrophy and hyperplasia. Lower cell density at these time points may indicate a more rapid increase in hepatocyte size compared with increasing cell number. If so, this would be in agreement with a previous report that the DNA content of term pregnant liver is approximately twice that of nonpregnant animals and that term pregnancy was associated with expression of cell proliferation markers [15] . Increased Ki67 expression in the liver of pregnant rodents has been reported to occur in the absence of mitotic figures [10] . One possible explanation is cell cycle arrest following the induction of mitosis leading to accumulation of DNA without an increase in cell number. Although this could explain lower liver cell density in mid and late gestation despite increased Ki67 and cyclin B1 expression, this interpretation is not consistent with the findings of the transcriptome-wide analysis. Late gestation was associated with hyperplasia; it was also associated with lower expression of mitotic markers. Together these findings suggest that hyperplasia was sufficient to support the modest increase in liver weight between nonpregnant and day 7 pregnant mice (9%), while both hyperplasia and hypertrophy were required for the increment in liver weight between pregnancy days 7 and 14 (13%). However, the substantial (36%) increase in liver weight between pregnancy days 14 and 18 required additional mechanisms.
The results of analysis of the effect of pregnancy on the expression of the liver transcriptome were validated by qRT-PCR. Combining the data sets from the current and published [22] results facilitated comprehensive analysis of the expression of the liver transcriptome during pregnancy. Comparison of pregnancy-associated changes in the liver transcriptome between mouse strains at similar gestational ages showed limited agreement at the level of individual genes (37% of differentially expressed genes were altered on both day 14 in C57BL/6 and d15 FVB mice and 25% of differentially Downloaded from https://academic.oup.com/biolreprod/article-abstract/97/5/762/4582254 by OUP site access user on 08 October 2018 expressed genes were altered on day 18 in C57BL/6 and day 19 in FVB mice). This may reflect, at least in part, innate differences and differences in the precise gestational age during periods of dynamic change between mouse strains and the use of different microarray platforms. Nevertheless, very similar pathways were altered in both C57BL/6 and FVB wild-type mice. This suggests that, irrespective of the gene-specific changes, there was a common drive between strains to change the activity of specific pathways which suggests that such adaptions are important for liver growth and function during pregnancy.
The combined findings of transcriptome-wide analysis of the livers of pregnant compared to nonpregnant C57BL/6 and FVB mice predicted that cell proliferation was increased at all time points measured between day 7.5 and day 19. Increased expression of three of the five genes that were most upregulated at gestational ages 14 and 18 days has been shown to be associated with cell proliferation. Liver cancer cells express higher levels of Kik1b4 [27] , possibly acting via hepatocyte growth factor [28] , Serpina6 [29] , and Nedd9 than nontransformed tissue. In addition, Snai3 is involved in cell differentiation during embryogenesis [30] , but has not been detected previously in adult liver. Decreased expression of four of the five genes that were most downregulated at gestational ages 14 and 18 days has been shown to be associated with cell proliferation. RNAi knockdown of the Cyp2b family of cytochrome P450 has been shown to induce increased liver weight [31] . Decreased expression of Abcc3 has been shown to be involved in liver cancer progression [32] and hepatocarcinoma cells express lower levels of Hamp than untransformed cells [33] . These findings are in agreement with previous studies that have shown upregulation of cell proliferationassociated genes in the liver of pregnant rodents [10, 15] and with the immunohistochemical analyses reported here.
Analysis of the predicted effects of the changes in expression of genes in the organismal death pathway in pregnant compared to nonpregnant mice indicated that apoptosis was downregulated between days 7.5 and 18, but not on day 19 when the expression of this pathway did not differ significantly from nonpregnant mice. These findings were confirmed by measurement of the mRNA expression of key genes in the apoptosis pathway: Trp53, Fas, and Casp6 [34] . This showed that Trp53 and Fas were downregulated by up to 50% between days 7 and 18, while Casp6 was only downregulated, albeit to a similar extent on days 14 and 18. The precise effect on apoptosis of such differential changes in expression cannot be deduced from these findings. However, since Trp53 and Fas act upstream of Casp6 [34] , it is likely that the net activity of the apoptosis pathway was downregulated at all time points that were measured. Furthermore, it is well established that downregulation of Trp53, acting via downregulation of apoptosis, can lead to cell proliferation associated with cancer [35] .
Together these findings show for the first time that the mRNA expression of genes involved in apoptosis is downregulated during pregnancy in mice. This suggests that in addition to increased cell proliferation and hyperplasia, liver growth in pregnancy also involves a reduction in cell death. This may be of particular importance in late gestation when the expression of genes involved in cell proliferation was decreased.
DNA methylation is an important epigenetic mechanism that regulates transcription [17] and which can be modified by a range of environmental inputs including hormones [36] . Reproductive tissues have been shown to exhibit function-related changes in DNA methylation. For example, lactation has been shown to be associated with hypomethylation and increased expression of genes encoding casein Csn2 and Csn3 in the mammary glands of mice [37] . The methylation status of the prostaglandin E receptor 2 gene has been shown to be associated positively, while methylation of long interspersed nuclear element (LINE)-1 was associated negatively with gestational age in women [38] . The present findings show lower average and CpG locus-specific methylation of LINE-1 at 14 and 18 days gestation, but not on day 7. The magnitude of the decrease was comparable to that reported in leukocytes of subjects exposed to air pollution [39] , in multiple sclerosis patients [40] and in early gastric cancer [41] . LINE-1 sequences account for over 20% of the mouse genome [42] , and the level of LINE-1 methylation has been shown to correlate with global DNA methylation [43, 44] . Hypomethylation of LINE-1 sequences has been reported to be associated with cell proliferation [45] , consistent with the findings here. Using MeDip and hMeDip-seq, we also report pregnancy-induced methylation changes, although the number of changes was very limited. Importantly, none of the altered regions were associated with differentially expressed genes. Thus, these findings do not support the suggestion that altered transcription in pregnancy involved changes in DNA methylation. However, this may reflect the fact that MeDip and hMeDIp-seq are relatively low resolution techniques that detect methylated regions of about 200 bp in length rather than individual CpG sites and so changes at individual CpG sites may be missed, as well as smaller changes in methylation such as those detected by pyrosequencing at LINE-1 sequences. DNA methylation status has been suggested to reflect the balance between DNA methyltransferase and demethylase activities [19] , the latter catalyzed putatively by Tet enzymes [46] . The present findings are consistent with a decrease in LINE-1 methylation in pregnancy such that lower DNA methylation in early pregnancy may be due to increased demethylase activity, but that in mid and late gestation both decreased methylation de novo and increased demethylation may be involved. If so, the involvement of Dnmt 3a and 3b may indicate that hypomethylation may be in proliferating rather than postmitotic cells.
The findings of this study show that the increase in maternal liver weight in mice during pregnancy involves integrated changes in cell size, proliferation, and apoptosis that differ between time points in gestation. We suggest the following model of liver growth in pregnancy ( Figure 6 ). In early pregnancy (days 7 and 7.5), activation of cell proliferation appears to underlie liver growth, rather than hypertrophy and downregulation of apoptosis. In mid pregnancy (days 14 and 15), the significant liver growth appears to involve hepatocyte hypertrophy, leading to lower cell density, increased cell proliferation, and decreased apoptosis. These changes persist into late gestation (days 18 and 19) , although the level of cell proliferation may decrease and apoptosis did not appear to be suppressed. Reactivation of apoptosis may contribute to postpartum reduction in liver size. One additional implication of these findings is that reduction in apoptosis may facilitate rapid increase in liver size while limiting nutritional demands on the mother for synthesis of new liver tissue.
Supplementary data
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Supplemental Figure S2 . Validation of the Illumina mRNA expression arrays by qRTPCR for the nine most altered genes on the arrays: Snail Family Transcriptional Repressor (snai), Solute Carrier Family 6 (Neurotransmitter Transporter, Glycine), Member 9 (Slc6a9), Complement Component 9 (C9), dimethylaminohydrolase (Ddah), cytochrome P450, family 2, subfamily c, polypeptide 50 Cyp2c50, cytochrome P450, family 2, subfamily b, polypeptide 13 (Cyp2b13). Statistical comparisons were by Student's unpaired t test.
Supplemental Figure S3 . IPA gene subcategories in maternal liver that were changed significantly on pregnancy d14 compared to nonpregnant (light blue) and pregnancy d18 compared to non-pregnant (dark blue).
Supplemental Figure S4 . Methylation status of the differentially methylated region (highlighted) in the zinc finger CCCH-type containing 12D (Zc3h12d) gene in liver from non-pregnant and d14 pregnant mice. CpG loci are indicated by bold text and by boxed numbers). Statistical comparisons were by Student's unpaired t test.
Supplemental Table S1 . Composition of the RM1 diet. Supplemental Table S2 . Quantitative RT-PCR primers. Supplemental Table S3 . Pyrosequencing PCR sequences and annealing temperatures.
Supplemental Table S4 . Top 10 most differentially expressed transcripts in liver from pregnant mice on day 14 and day 18 compared to nonpregnant animals. Table S5 . Top 10 most differentially expressed genes in the liver of pregnant compared to nonpregnant mice in the cell proliferation pathway.
Supplemental Table S6 . Top 10 most differentially expressed genes in the liver of pregnant compared to non-pregnant mice in the Organismal Death pathway.
